Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy : results from the CLEAR study
| dc.contributor.author | Ali, Nasloon | |
| dc.contributor.author | Chen, Stephanie | |
| dc.contributor.author | Tran, Trung N | |
| dc.contributor.author | Cook, Bill | |
| dc.contributor.author | Altraja, Alan | |
| dc.contributor.author | Bourdin, Arnaud | |
| dc.contributor.author | Sheu, Chau-Chyun | |
| dc.contributor.author | Tsai, Ming-Ju | |
| dc.contributor.author | Hoyte, Flavia C L | |
| dc.contributor.author | Quinton, Anna | |
| dc.contributor.author | Emmanuel, Benjamin | |
| dc.contributor.author | Goh, Celine Y.Y. | |
| dc.contributor.author | Carter, Victoria | |
| dc.contributor.author | Price, David | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-03-15T12:55:02Z | |
| dc.date.available | 2024-03-15T12:55:02Z | |
| dc.date.embargoedUntil | 2023-10-31 | |
| dc.date.issued | 2022-10 | |
| dc.description | Funding This study was funded by AstraZeneca. The International Severe Asthma Registry is jointly funded by Optimum Patient Care Global and AstraZeneca. Acknowledgments Medical writing support was provided by Madeleine Wynn, MRes, of PharmaGenesis London, London, UK, with funding from AstraZeneca. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 101786 | |
| dc.identifier | 284873778 | |
| dc.identifier | 056ea54f-cba5-45b8-8610-9d7ceae894e8 | |
| dc.identifier.citation | Ali, N, Chen, S, Tran, T N, Cook, B, Altraja, A, Bourdin, A, Sheu, C-C, Tsai, M-J, Hoyte, F C L, Quinton, A, Emmanuel, B, Goh, C Y Y, Carter, V & Price, D 2022, 'Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy : results from the CLEAR study', Chest, vol. 162, no. 4, Supplement, pp. A23-A27. https://doi.org/10.1016/j.chest.2022.08.019 | en |
| dc.identifier.doi | 10.1016/j.chest.2022.08.019 | |
| dc.identifier.iss | 4 | en |
| dc.identifier.issn | 0012-3692 | |
| dc.identifier.other | RIS: urn:5B299337B85A3F282CF0E6930F86FDB6 | |
| dc.identifier.other | RIS: urn:5B299337B85A3F282CF0E6930F86FDB6 | |
| dc.identifier.uri | https://hdl.handle.net/2164/23031 | |
| dc.identifier.vol | 162 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Chest | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Clinical outcomes and emergency healthcare utilization in patients with severe asthma who continued, switched or stopped biologic therapy : results from the CLEAR study | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Ali_etal_CHEST_Clinical_Outcomes_And_AAM.pdf
- Size:
- 99.4 KB
- Format:
- Adobe Portable Document Format
